Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Dmytriiev (Vinnytsia, Ukraine), Y. Mostovoy (Vinnytsia, Ukraine), N. Slepchenko (Vinnytsia, Ukraine), N. Tsymbaliuk (Vinnytsia, Ukraine), A. Sidorov (Vinnytsia, Ukraine). Budesoinde/formoterol: does eosinophil count cause different outcomes?. 4245

Member's Comments

No comment yet.

Related content which might interest you: Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 Association between blood eosinophil count and control of allergic rhinitis: does it exist? Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Blood eosinophil count in the general population: typical values and potential confounders Source: Eur Respir J, 55 (5) 1901874; 10.1183/13993003.01874-2019 Year: 2020 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Definition of COPD phenotype depending on eosinophil count Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients? Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no! Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018 Year: 2018 An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity? Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 BAL cell counts in the diagnosis of lung diseases: is there a gain in information? Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002 Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up. Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 High eosinophil counts predict decline in FEV1: results from the CanCOLD study Source: Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020 Year: 2021 Changes in eosinophil count and C reactive protein following treatment with mebendazole in patients with Toxocara-associated asthma Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017